The decision by Astrazeneca chief executive Pascal Soriot (pictured) to place the pharma group’s resources behind the Oxford Jenner Institute’s vaccine is paying off brilliantly.
ALEX BRUMMER: UK live sciences have risen to the challenge of Covid-19
Something you may find interesting…
[recent_products per_page="4" columns="4" orderby="rand" order="rand"]